Brian Meehan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Brian Meehan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Christopher E. Rudd
Department of Medicine, Université de Montréal, Montreal, Canada
1 shared publication - Dongsic Choi
Department of Biochemistry, College of Medicine, Soonchunhyang University, Cheonan 31511, Republic of Korea
1 shared publication - Janusz Rak
McGill University, The Research Institute of the McGill University Health Centre, Montreal, Canada
1 shared publication - Lata Adnani
Sunnybrook Research Institute, Toronto, ON, Canada
1 shared publication - Minjun Kim
Victor Phillip Dahdaleh Institute of Genomic Medicine at McGill University. McGill University Department of Human Genetics, Montreal, QC, Canada
1 shared publication - Yasser Riazalhosseini
Department of Human Genetics, McGill University, Montreal, QC, Canada; Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Canada
1 shared publication
Latest Publications
- Open Access
- 23 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (21) , eadr6940
Immune cell infiltration into brain tumor microenvironment is mediated by Rab27-regulated vascular wall integrity
Aggressive brain tumors often exhibit immunologically ‘cold’ microenvironment, where the vascular barrier impedes effective immunotherapy in poorly understood ways. Tumor vasculature also plays a pivotal role in immunoregulation and antitumor immunity. Here, we show that small GTPase Rab27 controls the vascular morphogenesis and permeability for blood content and immune effectors. Thus, in Rab27a/b double knock out (Rab27-dKO) mice, the brain vasculature is abnormally scarce, while the blood vessels become dysmorphic and hyperpermeable in the context of brain tumors, including syngeneic glioblastoma. These defects are reflected in rearrangements of endothelial cell subpopulations with underlying diminution of venous endothelial subtype along with changes in gene and protein expression. Notably, Rab27-dKO brain endothelial cells exhibit deficient tight junctions, whereby they enable large-scale extravasation of cytotoxic T cells into the tumor mass. We show that Rab27-regulated vascular T cell infiltration can be exploited to enhance adoptive T cell therapy in syngeneic brain tumors.
- 23 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (21) , eadr6940
Open AccessImmune cell infiltration into brain tumor microenvironment is mediated by Rab27-regulated vascular wall integrity
Aggressive brain tumors often exhibit immunologically ‘cold’ microenvironment, where the vascular barrier impedes effective immunotherapy in poorly understood ways. Tumor vasculature also plays a pivotal role in immunoregulation and antitumor immunity. Here, we show that small GTPase Rab27 controls the vascular morphogenesis and permeability for blood content and immune effectors. Thus, in Rab27a/b double knock out (Rab27-dKO) mice, the brain vasculature is abnormally scarce, while the blood vessels become dysmorphic and hyperpermeable in the context of brain tumors, including syngeneic glioblastoma. These defects are reflected in rearrangements of endothelial cell subpopulations with underlying diminution of venous endothelial subtype along with changes in gene and protein expression. Notably, Rab27-dKO brain endothelial cells exhibit deficient tight junctions, whereby they enable large-scale extravasation of cytotoxic T cells into the tumor mass. We show that Rab27-regulated vascular T cell infiltration can be exploited to enhance adoptive T cell therapy in syngeneic brain tumors.